Drugs / MS-R001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00401115 | Sep 2006 → Jun 2008 | diabetic macular edema | Santen Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MS-R001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00401115 ↗ |
| Known as | rapamycin | “MS-R001 (rapamycin)” NCT00401115 ↗ |
| Route | Other | “Subconjunctival injection” NCT00401115 ↗ |